Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
Applied Health Economics and Health Policy, 10/20/09
Golec J et al. – Biotech firms' financial risks increase their costs of capital and make them more sensitive to government regulations that affect their financial prospects. As biotech products grow to represent a larger share of new medicines, general stock market conditions and government regulations could have a greater impact on the level of innovation of new medicines.
Related Articles
Contribution of Para-transit Vehicles to Welfare Services
Chugai Pharmaceutical Co., 10/14/09
Relevance Score: 67%
Implementing a comprehensive, 24-hour emergency department pharmacy program
American Journal of Health-System Pharmacy, 10/26/09
Relevance Score: 66%
Drug firm sues to end off-label marketing ban
American Medical News, 10/23/09
Relevance Score: 65%
Contribution of Para-transit Vehicles to Welfare Services
Chugai Pharmaceutical Co., 10/16/09
Relevance Score: 65%
Contribution of Para-transit Vehicles to Welfare Services
Chugai Pharmaceutical Co., 10/06/09
Relevance Score: 65%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
"Better Ways to Pay for Health Care", Recommended by National Health Care Quality Coalition
AMN Healthcare, 11/25/09
Stimulating EMR adoption
American Medical News , 11/25/09
Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09
Article Search
Sponsor


See Latest Articles


